MTOR and adrenal cortex carcinoma: One female patient presenting with hypoglycemia secondary to metastatic ACC was trialed on everolimus, an mTOR inhibitor previously shown to be effective in the management of insulinoma-induced hypoglycemia [21], with no clinical response [7].